Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Bipolar Disorders and Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Mood Stabilizer
1.2.3 Anticonvulsant
1.2.4 Antipsychotic
1.2.5 Antidepressant
1.2.6 Antianxiety
1.3 Market by Sale Channel
1.3.1 Global Bipolar Disorders and Treatment Market Growth by Sale Channel: 2018 VS 2022 VS 2033
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Bipolar Disorders and Treatment Market Perspective (2018-2033)
2.2 Bipolar Disorders and Treatment Growth Trends by Region
2.2.1 Global Bipolar Disorders and Treatment Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Bipolar Disorders and Treatment Historic Market Size by Region (2018-2023)
2.2.3 Bipolar Disorders and Treatment Forecasted Market Size by Region (2024-2033)
2.3 Bipolar Disorders and Treatment Market Dynamics
2.3.1 Bipolar Disorders and Treatment Industry Trends
2.3.2 Bipolar Disorders and Treatment Market Drivers
2.3.3 Bipolar Disorders and Treatment Market Challenges
2.3.4 Bipolar Disorders and Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Bipolar Disorders and Treatment Players by Revenue
3.1.1 Global Top Bipolar Disorders and Treatment Players by Revenue (2018-2023)
3.1.2 Global Bipolar Disorders and Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Bipolar Disorders and Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Bipolar Disorders and Treatment Revenue
3.4 Global Bipolar Disorders and Treatment Market Concentration Ratio
3.4.1 Global Bipolar Disorders and Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Bipolar Disorders and Treatment Revenue in 2022
3.5 Bipolar Disorders and Treatment Key Players Head office and Area Served
3.6 Key Players Bipolar Disorders and Treatment Product Solution and Service
3.7 Date of Enter into Bipolar Disorders and Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Bipolar Disorders and Treatment Breakdown Data by Type
4.1 Global Bipolar Disorders and Treatment Historic Market Size by Type (2018-2023)
4.2 Global Bipolar Disorders and Treatment Forecasted Market Size by Type (2024-2033)
5 Bipolar Disorders and Treatment Breakdown Data by Sale Channel
5.1 Global Bipolar Disorders and Treatment Historic Market Size by Sale Channel (2018-2023)
5.2 Global Bipolar Disorders and Treatment Forecasted Market Size by Sale Channel (2024-2033)
6 North America
6.1 North America Bipolar Disorders and Treatment Market Size (2018-2033)
6.2 North America Bipolar Disorders and Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Bipolar Disorders and Treatment Market Size by Country (2018-2023)
6.4 North America Bipolar Disorders and Treatment Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Bipolar Disorders and Treatment Market Size (2018-2033)
7.2 Europe Bipolar Disorders and Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Bipolar Disorders and Treatment Market Size by Country (2018-2023)
7.4 Europe Bipolar Disorders and Treatment Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Bipolar Disorders and Treatment Market Size (2018-2033)
8.2 Asia-Pacific Bipolar Disorders and Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Bipolar Disorders and Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Bipolar Disorders and Treatment Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Bipolar Disorders and Treatment Market Size (2018-2033)
9.2 Latin America Bipolar Disorders and Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Bipolar Disorders and Treatment Market Size by Country (2018-2023)
9.4 Latin America Bipolar Disorders and Treatment Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Bipolar Disorders and Treatment Market Size (2018-2033)
10.2 Middle East & Africa Bipolar Disorders and Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Bipolar Disorders and Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Bipolar Disorders and Treatment Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Detail
11.1.2 GlaxoSmithKline Business Overview
11.1.3 GlaxoSmithKline Bipolar Disorders and Treatment Introduction
11.1.4 GlaxoSmithKline Revenue in Bipolar Disorders and Treatment Business (2018-2023)
11.1.5 GlaxoSmithKline Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Detail
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Bipolar Disorders and Treatment Introduction
11.2.4 Pfizer Revenue in Bipolar Disorders and Treatment Business (2018-2023)
11.2.5 Pfizer Recent Development
11.3 Janssen Pharmaceuticals
11.3.1 Janssen Pharmaceuticals Company Detail
11.3.2 Janssen Pharmaceuticals Business Overview
11.3.3 Janssen Pharmaceuticals Bipolar Disorders and Treatment Introduction
11.3.4 Janssen Pharmaceuticals Revenue in Bipolar Disorders and Treatment Business (2018-2023)
11.3.5 Janssen Pharmaceuticals Recent Development
11.4 Eli Lilly
11.4.1 Eli Lilly Company Detail
11.4.2 Eli Lilly Business Overview
11.4.3 Eli Lilly Bipolar Disorders and Treatment Introduction
11.4.4 Eli Lilly Revenue in Bipolar Disorders and Treatment Business (2018-2023)
11.4.5 Eli Lilly Recent Development
11.5 Allergan
11.5.1 Allergan Company Detail
11.5.2 Allergan Business Overview
11.5.3 Allergan Bipolar Disorders and Treatment Introduction
11.5.4 Allergan Revenue in Bipolar Disorders and Treatment Business (2018-2023)
11.5.5 Allergan Recent Development
11.6 Novartis
11.6.1 Novartis Company Detail
11.6.2 Novartis Business Overview
11.6.3 Novartis Bipolar Disorders and Treatment Introduction
11.6.4 Novartis Revenue in Bipolar Disorders and Treatment Business (2018-2023)
11.6.5 Novartis Recent Development
11.7 ​​AbbVie
11.7.1 ​​AbbVie Company Detail
11.7.2 ​​AbbVie Business Overview
11.7.3 ​​AbbVie Bipolar Disorders and Treatment Introduction
11.7.4 ​​AbbVie Revenue in Bipolar Disorders and Treatment Business (2018-2023)
11.7.5 ​​AbbVie Recent Development
11.8 Otsuka Holdings
11.8.1 Otsuka Holdings Company Detail
11.8.2 Otsuka Holdings Business Overview
11.8.3 Otsuka Holdings Bipolar Disorders and Treatment Introduction
11.8.4 Otsuka Holdings Revenue in Bipolar Disorders and Treatment Business (2018-2023)
11.8.5 Otsuka Holdings Recent Development
11.9 AstraZeneca
11.9.1 AstraZeneca Company Detail
11.9.2 AstraZeneca Business Overview
11.9.3 AstraZeneca Bipolar Disorders and Treatment Introduction
11.9.4 AstraZeneca Revenue in Bipolar Disorders and Treatment Business (2018-2023)
11.9.5 AstraZeneca Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Bipolar Disorders and Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Mood Stabilizer
Table 3. Key Players of Anticonvulsant
Table 4. Key Players of Antipsychotic
Table 5. Key Players of Antidepressant
Table 6. Key Players of Antianxiety
Table 7. Global Bipolar Disorders and Treatment Market Size Growth by Sale Channel (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Bipolar Disorders and Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 9. Global Bipolar Disorders and Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Bipolar Disorders and Treatment Market Share by Region (2018-2023)
Table 11. Global Bipolar Disorders and Treatment Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 12. Global Bipolar Disorders and Treatment Market Share by Region (2024-2033)
Table 13. Bipolar Disorders and Treatment Market Trends
Table 14. Bipolar Disorders and Treatment Market Drivers
Table 15. Bipolar Disorders and Treatment Market Challenges
Table 16. Bipolar Disorders and Treatment Market Restraints
Table 17. Global Bipolar Disorders and Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Bipolar Disorders and Treatment Market Share by Players (2018-2023)
Table 19. Global Top Bipolar Disorders and Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bipolar Disorders and Treatment as of 2022)
Table 20. Ranking of Global Top Bipolar Disorders and Treatment Companies by Revenue (US$ Million) in 2022
Table 21. Global 5 Largest Players Market Share by Bipolar Disorders and Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Bipolar Disorders and Treatment Product Solution and Service
Table 24. Date of Enter into Bipolar Disorders and Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Bipolar Disorders and Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Bipolar Disorders and Treatment Revenue Market Share by Type (2018-2023)
Table 28. Global Bipolar Disorders and Treatment Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 29. Global Bipolar Disorders and Treatment Revenue Market Share by Type (2024-2033)
Table 30. Global Bipolar Disorders and Treatment Market Size by Sale Channel (2018-2023) & (US$ Million)
Table 31. Global Bipolar Disorders and Treatment Revenue Market Share by Sale Channel (2018-2023)
Table 32. Global Bipolar Disorders and Treatment Forecasted Market Size by Sale Channel (2024-2033) & (US$ Million)
Table 33. Global Bipolar Disorders and Treatment Revenue Market Share by Sale Channel (2024-2033)
Table 34. North America Bipolar Disorders and Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. North America Bipolar Disorders and Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 36. North America Bipolar Disorders and Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 37. Europe Bipolar Disorders and Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 38. Europe Bipolar Disorders and Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 39. Europe Bipolar Disorders and Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 40. Asia-Pacific Bipolar Disorders and Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 41. Asia-Pacific Bipolar Disorders and Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 42. Asia-Pacific Bipolar Disorders and Treatment Market Size by Region (2024-2033) & (US$ Million)
Table 43. Latin America Bipolar Disorders and Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Latin America Bipolar Disorders and Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 45. Latin America Bipolar Disorders and Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 46. Middle East & Africa Bipolar Disorders and Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 47. Middle East & Africa Bipolar Disorders and Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 48. Middle East & Africa Bipolar Disorders and Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 49. GlaxoSmithKline Company Detail
Table 50. GlaxoSmithKline Business Overview
Table 51. GlaxoSmithKline Bipolar Disorders and Treatment Product
Table 52. GlaxoSmithKline Revenue in Bipolar Disorders and Treatment Business (2018-2023) & (US$ Million)
Table 53. GlaxoSmithKline Recent Development
Table 54. Pfizer Company Detail
Table 55. Pfizer Business Overview
Table 56. Pfizer Bipolar Disorders and Treatment Product
Table 57. Pfizer Revenue in Bipolar Disorders and Treatment Business (2018-2023) & (US$ Million)
Table 58. Pfizer Recent Development
Table 59. Janssen Pharmaceuticals Company Detail
Table 60. Janssen Pharmaceuticals Business Overview
Table 61. Janssen Pharmaceuticals Bipolar Disorders and Treatment Product
Table 62. Janssen Pharmaceuticals Revenue in Bipolar Disorders and Treatment Business (2018-2023) & (US$ Million)
Table 63. Janssen Pharmaceuticals Recent Development
Table 64. Eli Lilly Company Detail
Table 65. Eli Lilly Business Overview
Table 66. Eli Lilly Bipolar Disorders and Treatment Product
Table 67. Eli Lilly Revenue in Bipolar Disorders and Treatment Business (2018-2023) & (US$ Million)
Table 68. Eli Lilly Recent Development
Table 69. Allergan Company Detail
Table 70. Allergan Business Overview
Table 71. Allergan Bipolar Disorders and Treatment Product
Table 72. Allergan Revenue in Bipolar Disorders and Treatment Business (2018-2023) & (US$ Million)
Table 73. Allergan Recent Development
Table 74. Novartis Company Detail
Table 75. Novartis Business Overview
Table 76. Novartis Bipolar Disorders and Treatment Product
Table 77. Novartis Revenue in Bipolar Disorders and Treatment Business (2018-2023) & (US$ Million)
Table 78. Novartis Recent Development
Table 79. ​​AbbVie Company Detail
Table 80. ​​AbbVie Business Overview
Table 81. ​​AbbVie Bipolar Disorders and Treatment Product
Table 82. ​​AbbVie Revenue in Bipolar Disorders and Treatment Business (2018-2023) & (US$ Million)
Table 83. ​​AbbVie Recent Development
Table 84. Otsuka Holdings Company Detail
Table 85. Otsuka Holdings Business Overview
Table 86. Otsuka Holdings Bipolar Disorders and Treatment Product
Table 87. Otsuka Holdings Revenue in Bipolar Disorders and Treatment Business (2018-2023) & (US$ Million)
Table 88. Otsuka Holdings Recent Development
Table 89. AstraZeneca Company Detail
Table 90. AstraZeneca Business Overview
Table 91. AstraZeneca Bipolar Disorders and Treatment Product
Table 92. AstraZeneca Revenue in Bipolar Disorders and Treatment Business (2018-2023) & (US$ Million)
Table 93. AstraZeneca Recent Development
Table 94. Research Programs/Design for This Report
Table 95. Key Data Information from Secondary Sources
Table 96. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Bipolar Disorders and Treatment Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Bipolar Disorders and Treatment Market Share by Type: 2022 VS 2033
Figure 3. Mood Stabilizer Features
Figure 4. Anticonvulsant Features
Figure 5. Antipsychotic Features
Figure 6. Antidepressant Features
Figure 7. Antianxiety Features
Figure 8. Global Bipolar Disorders and Treatment Market Size Comparison by Sale Channel (2023-2033) & (US$ Million)
Figure 9. Global Bipolar Disorders and Treatment Market Share by Sale Channel: 2022 VS 2033
Figure 10. Hospital Case Studies
Figure 11. Pharmacy Case Studies
Figure 12. Other Case Studies
Figure 13. Bipolar Disorders and Treatment Report Years Considered
Figure 14. Global Bipolar Disorders and Treatment Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 15. Global Bipolar Disorders and Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 16. Global Bipolar Disorders and Treatment Market Share by Region: 2022 VS 2033
Figure 17. Global Bipolar Disorders and Treatment Market Share by Players in 2022
Figure 18. Global Top Bipolar Disorders and Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bipolar Disorders and Treatment as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Bipolar Disorders and Treatment Revenue in 2022
Figure 20. North America Bipolar Disorders and Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. North America Bipolar Disorders and Treatment Market Share by Country (2018-2033)
Figure 22. United States Bipolar Disorders and Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Canada Bipolar Disorders and Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Bipolar Disorders and Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Europe Bipolar Disorders and Treatment Market Share by Country (2018-2033)
Figure 26. Germany Bipolar Disorders and Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. France Bipolar Disorders and Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. U.K. Bipolar Disorders and Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Italy Bipolar Disorders and Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Russia Bipolar Disorders and Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Nordic Countries Bipolar Disorders and Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Asia-Pacific Bipolar Disorders and Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Asia-Pacific Bipolar Disorders and Treatment Market Share by Region (2018-2033)
Figure 34. China Bipolar Disorders and Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Japan Bipolar Disorders and Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. South Korea Bipolar Disorders and Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Southeast Asia Bipolar Disorders and Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. India Bipolar Disorders and Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Australia Bipolar Disorders and Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Latin America Bipolar Disorders and Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Latin America Bipolar Disorders and Treatment Market Share by Country (2018-2033)
Figure 42. Mexico Bipolar Disorders and Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Brazil Bipolar Disorders and Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Middle East & Africa Bipolar Disorders and Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Middle East & Africa Bipolar Disorders and Treatment Market Share by Country (2018-2033)
Figure 46. Turkey Bipolar Disorders and Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Saudi Arabia Bipolar Disorders and Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. GlaxoSmithKline Revenue Growth Rate in Bipolar Disorders and Treatment Business (2018-2023)
Figure 49. Pfizer Revenue Growth Rate in Bipolar Disorders and Treatment Business (2018-2023)
Figure 50. Janssen Pharmaceuticals Revenue Growth Rate in Bipolar Disorders and Treatment Business (2018-2023)
Figure 51. Eli Lilly Revenue Growth Rate in Bipolar Disorders and Treatment Business (2018-2023)
Figure 52. Allergan Revenue Growth Rate in Bipolar Disorders and Treatment Business (2018-2023)
Figure 53. Novartis Revenue Growth Rate in Bipolar Disorders and Treatment Business (2018-2023)
Figure 54. ​​AbbVie Revenue Growth Rate in Bipolar Disorders and Treatment Business (2018-2023)
Figure 55. Otsuka Holdings Revenue Growth Rate in Bipolar Disorders and Treatment Business (2018-2023)
Figure 56. AstraZeneca Revenue Growth Rate in Bipolar Disorders and Treatment Business (2018-2023)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed